Treatment of Cirrhosis
The treatment of cirrhosis should focus on addressing the underlying cause of liver disease, managing complications, and implementing sodium restriction (88 mmol/day [2000 mg/day]) with diuretic therapy (spironolactone with or without furosemide) as first-line treatment for ascites. 1, 2
Addressing the Underlying Cause
Treating the underlying cause of cirrhosis is crucial for preventing disease progression:
- Alcohol-related cirrhosis: Complete abstinence from alcohol is essential. Patients who stop drinking have approximately 75% 3-year survival, while those who continue drinking have significantly worse outcomes 1
- Viral hepatitis: Antiviral therapy for hepatitis B or C can improve liver function and potentially reverse fibrosis 1, 2
- Nonalcoholic fatty liver disease: Weight loss and metabolic control are primary interventions 2, 3
- Autoimmune hepatitis: Immunosuppressive therapy 2
Management of Ascites
Ascites is a common complication requiring prompt intervention:
Dietary sodium restriction:
Diuretic therapy:
- First presentation of moderate ascites: Start with spironolactone monotherapy (100 mg daily, can increase to 400 mg) 1, 4
- Recurrent or severe ascites: Combination therapy with spironolactone (100-400 mg) and furosemide (40-160 mg) 1, 2
- Monitor for adverse effects including hyponatremia, hyperkalemia, and renal dysfunction 1
Large volume paracentesis (LVP):
Management of Other Complications
Spontaneous Bacterial Peritonitis (SBP)
- Diagnostic paracentesis should be performed in all cirrhotic patients with ascites on hospital admission 1
- Immediate empirical antibiotic therapy when SBP is suspected 1
- Prophylactic antibiotics (norfloxacin 400 mg daily or ciprofloxacin 500 mg daily) for high-risk patients 1, 2
Esophageal Varices
- Regular endoscopic surveillance (every 1-3 years depending on cirrhosis severity) 1, 2
- Non-selective beta-blockers (propranolol or carvedilol) for prophylaxis 1, 3
Hepatic Encephalopathy
- Lactulose is first-line therapy 2, 3
- Rifaximin can be added for refractory cases 3, 5
- Identify and treat precipitating factors (infection, GI bleeding, electrolyte imbalances) 6
Monitoring and Follow-up
- Regular assessment of liver function tests every 6 months 7, 5
- Calculate Child-Pugh and MELD scores to assess disease severity 7
- Screen for hepatocellular carcinoma with ultrasound every 6 months 2, 5
- Consider referral for liver transplantation evaluation for decompensated cirrhosis 2, 3
Important Precautions
- Avoid nephrotoxic medications, especially NSAIDs 1, 2
- Fluid restriction is only necessary for severe hyponatremia (serum sodium <125 mmol/L) 1, 2
- Avoid starch-based volume expanders 1
- Use a restrictive transfusion strategy (hemoglobin threshold of 7 g/dl) in patients with GI bleeding 1
Nutritional Support
- Ensure adequate caloric intake (35-40 kcal/kg/day) and protein intake (1.2-1.5 g/kg/day) 2
- Consider branched-chain amino acid supplementation for patients with hepatic encephalopathy 2
The management of cirrhosis requires a comprehensive approach targeting the underlying cause while preventing and treating complications. Early intervention is critical to prevent disease progression and improve quality of life and survival.